腦腫瘤藥物市場報告：2030 年趨勢、預測與競爭分析

腦腫瘤治療藥物的趨勢與預測

2024年至2030年，全球腦腫瘤治療市場預計將以8.7%的複合年成長率成長。該市場的主要促進因素是吸煙率上升、人口老化、壓力和電磁輻射暴露。全球腦腫瘤治療市場前景未來性，醫院藥局和零售/線上藥局市場充滿機會。

腦腫瘤治療藥物按細分市場

該研究包括按治療、適應症、分銷管道和地區對全球腦腫瘤藥物的預測。

腦腫瘤藥物市場洞察

Lucintel 預測，化療（輔助性治療）在預測期內仍將是最大的細分市場。

醫院藥局將繼續佔據該市場的很大一部分，因為治療腦腫瘤的藥物是處方藥，必須在醫院內使用。

由於有利的報銷政策和新藥上市的增加，北美在預測期內可能仍然是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球腦腫瘤治療藥物市場預計將以8.7%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要促進因素是吸煙率上升、人口老化、壓力和電磁輻射暴露。

Q3.市場的主要細分市場是：

A3.腦腫瘤治療藥物市場前景廣闊，醫院藥局市場和零售/網路藥局市場都有機會。

Q4.市場的主要企業是：

A4. 生產腦腫瘤治療藥物的主要企業如下：

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計化療（輔助性治療）在預測期內仍將是其最大的細分市場。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於有利的報銷政策和新藥市場投放的增加，北美在預測期內仍然是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球腦腫瘤藥物市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球腦腫瘤治療藥物市場趨勢（2018-2023）與預測（2024-2030）
• 全球腦腫瘤藥物市場：依治療分類
  • 標靶治療
  • 化療
  • 免疫療法
  • 其他
• 全球腦腫瘤藥物市場：依適應症分類
  • 腦下垂體
  • 腦膜瘤
  • 神經膠質瘤
  • 其他
• 全球腦腫瘤藥物市場：按分銷管道
  • 醫院藥房
  • 零售/網路藥房

第4章 2018-2030年區域市場趨勢及預測分析

• 全球腦腫瘤藥物市場（按地區）
• 北美腦腫瘤藥物市場
• 歐洲腦腫瘤藥物市場
• 亞太地區腦腫瘤藥物市場
• 其他地區腦腫瘤藥物市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
• 全球腦腫瘤藥物市場新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球腦腫瘤藥物市場的產能
  • 全球腦腫瘤藥物市場的合併、收購與合資
  • 認證和許可

第7章主要企業概況

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Trends and Forecast

The future of the global brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets. The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are rising prevalence of smoking, increasing aging population, and stress and exposure to electromagnetic radiation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Brain Tumor Drug by Segment

The study includes a forecast for the global brain tumor drug by therapy, indication, distribution channel, and region.

Brain Tumor Drug Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Others

Brain Tumor Drug Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Pituitary
• Meningioma
• Glioma
• Others

Brain Tumor Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail & Online Pharmacy

Brain Tumor Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Brain Tumor Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain tumor drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain tumor drug companies profiled in this report include-

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Market Insights

Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Within this market, hospital pharmacy will remain larger segment as drugs designed to treat the condition are prescribed and necessitate administration within hospital settings.

North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Features of the Global Brain Tumor Drug Market

Market Size Estimates: Brain tumor drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain tumor drug market size by therapy, indication, distribution channel, and region in terms of value ($B).

Regional Analysis: Brain tumor drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapy, indication, distribution channels, and regions for the brain tumor drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain tumor drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for brain tumor drug market?

Answer: The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the brain tumor drug market?

Answer: The major drivers for this market are rising prevalence of smoking, increasing aging population and stress and exposure to electromagnetic radiation.

Q3. What are the major segments for brain tumor drug market?

Answer: The future of the brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets.

Q4. Who are the key brain tumor drug market companies?

Answer: Some of the key brain tumor drug companies are as follows:

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5. Which brain tumor drug market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Q6. In brain tumor drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain tumor drug market by therapy (targeted therapy, chemotherapy, immunotherapy, and others), indication (pituitary, meningioma, glioma, and others), distribution channel (hospital pharmacy and retail & online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Tumor Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Brain Tumor Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Brain Tumor Drug Market by Therapy
  • 3.3.1: Targeted Therapy
  • 3.3.2: Chemotherapy
  • 3.3.3: Immunotherapy
  • 3.3.4: Others
• 3.4: Global Brain Tumor Drug Market by Indication
  • 3.4.1: Pituitary
  • 3.4.2: Meningioma
  • 3.4.3: Glioma
  • 3.4.4: Others
• 3.5: Global Brain Tumor Drug Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail & Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Brain Tumor Drug Market by Region
• 4.2: North American Brain Tumor Drug Market
  • 4.2.1: North American Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.2.2: North American Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.3: European Brain Tumor Drug Market
  • 4.3.1: European Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.3.2: European Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.4: APAC Brain Tumor Drug Market
  • 4.4.1: APAC Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.4.2: APAC Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.5: ROW Brain Tumor Drug Market
  • 4.5.1: ROW Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.5.2: ROW Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Tumor Drug Market by Therapy
  • 6.1.2: Growth Opportunities for the Global Brain Tumor Drug Market by Indication
  • 6.1.3: Growth Opportunities for the Global Brain Tumor Drug Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Brain Tumor Drug Market by Region
• 6.2: Emerging Trends in the Global Brain Tumor Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Tumor Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Tumor Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Pfizer
• 7.3: Novartis
• 7.4: Amgen
• 7.5: Merck & Co